A case of generalized edema associated with risperidone monotherapy

Amaç & Hipotez:Risperidone is a second-generation antipsychotic agent, widely used in psychiatric disorders like schizophrenia, bipolar disorder, and aggression.

📊

Temel Bulgular & Veri:Edema has been reported as a side effect of risperidone in a few case reports in the literature.

💡

Sonuç & Katkı:Here we aimed to report a case of generalized edema due to risperidone oral monotherapy and reviewed the relevant literature.

🔬Tür:Literatür & Derleme Çalışması

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Risperidone is a second-generation antipsychotic agent, widely used in psychiatric disorders like schizophrenia, bipolar disorder, and aggression. Edema has been reported as a side effect of risperidone in a few case reports in the literature. In most of these cases, another drug was combined with risperidone and edema was located in a specific zone. Here we aimed to report a case of generalized edema due to risperidone oral monotherapy and reviewed the relevant literature.

Abstract

Risperidon şizofreni, bipolar bozukluk, agresyon gibi psikiyatrik bozukluklarda yaygın olarak kullanılan bir ikinci jenerasyon antipsikotik ilaçtır. Ödem, literatürde risperidonun bir yan etkisi olarak az sayıda vakada bildirilmiştir. Bu vakaların çoğunda risperidon bir başka ilaçla kombine kullanılmıştır ve ödem yan etkisi vücudun belirli bir bölgesinde lokalizedir. Bu yazıda tek başına oral risperidon kullanımına bağlı gelişen bir yaygın ödem olgusunu sunmayı ve bu konuyla ilgili literatürü gözden geçirmeyi amaçladık.

🔖

Bu Makaleye Atıf Yap

ASAN, Ö., YAYLACI, E. T., GÖKA, E. (2019). A case of generalized edema associated with risperidone monotherapy. Klinik Psikiyatri Dergisi, Cilt: 22 - Sayı: 4, 501–503. https://ajindex.com/articles/194590

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

Tamam L, Ozpoyraz N, Unal M. Oedema associated with risperidone. Clin Drug Invest 2002; 22:411–414
Gunes F, Batgi H, Akbal A, Canatan T. Angioedema – an unusual serious side effect of risperidone injection. Clin Toxicol (Phila) 2013; 51:122–123
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Greenblatt DJ. A model for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245
Yang HN, Cheng YM. Peripheral edema associated with risperidone oral solution. A case report and a review of the literature. J Clin Psychopharmacol 2012; 32:128–130
Franco K, Tamburrino M, Campbell N, Pentz J, Evans C. Dopaminergic activity and idiopathic edema. Hosp Community Psychiatry 1991; 42:309–310
Knox ED, Stimmel GL. Clinical review of a long-acting, injectable formulation of risperidone. Clin Ther 2004; 26:1994– 2002
Akdag ST, Fettahoglu EC, Ozatalay E. Pedal edema induced by low-dose risperidone monotheraphy in a child. J Child Adolesc Psychopharmacol 2009; 19:481–482
Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005; 53:373–388
Terao T, Kojima H, Eto A. Risperidone and allergic reaction. J Clin Psychiatry 1998; 59:82–83
Pelizza L. Long-acting risperidone-induced periorbital edema. J Clin Psychopharmacol 2008; 28:709-710
Yang HN, Cheng YM. Peripheral edema associated with risperidone oral solution: a case report and a review of the literature. J Clin Psychopharmacol 2012; 32:128-130
Tunç S, Başbuğ HS. Leg oedema due to low-dose risperidone during maintenance monotherapy of schizophrenia. Psychiatry and Clinical Psychopharmacology 2018; 28:104-106.